Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease

Clinical trial NCT04146155 · UNKNOWN

Trial details

NCT number: NCT04146155
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Peripheral Vascular Disorder Due to Diabetes Mellitus

Start date: 2020-05-01
Primary completion: 2021-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.